Hacker News new | ask | show | jobs
by peet2521 1097 days ago
I came to the comment section to mention other seratonergic drugs that do something similar to what the study mentions. Psilocin is a serotonin 2A agonist, LSD is a 1A agonist (according to a quick google search), and this new drug works on "4" receptors. All of which seem to have similar beneficial therapeutic effects when used properly.

In general, I'm very excited to see drugs like these being researched, including previously illegal "schedule 1" drugs that can (and probably should) be used in therapeutic settings.

If you're looking for some good content to learn more about this, Andrew Huberman is currently doing a handful of podcasts on drugs like these, and it's really educational. (Assuming you can handle his long-form podcast style)

2 comments

> I came to the comment section to mention other seratonergic drugs that do something similar to what the study mentions. Psilocin is a serotonin 2A agonist, LSD is a 1A agonist (according to a quick google search), and this new drug works on "4" receptors. All of which seem to have similar beneficial therapeutic effects when used properly.

Serotonin receptors are not interchangeable at all.

5-HT2A and 5-HT4 receptors have completely different effects and functions. You can’t suggest that drugs that work on one are similar to the other.

They are nothing alike.

"If you're looking for some good content to learn more about this" I can also recommend the book How To Change Your mind by Michael Pollan.